Bram Gerritsen
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
-
- HIV Research and Treatment
Papers in
-
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 2
- Immune Response and Inflammation 1
- Oncology 2
- CAR-T cell therapy research 2
- Co-authors
- Aridaman Pandit (3 shared papers)Rob J. de Boer (3 shared papers)Arno C. Andeweg (2 shared papers)David A. Price (2 shared papers)Kristin Ladell (2 shared papers)Can Keşmir (2 shared papers)James E. McLaren (2 shared papers)Gwendolyn Swarbrick (1 shared paper)
- Journals
- eLife (1 paper)The Journal of Experimental Medicine (1 paper)Cell Reports (1 paper)Immunology and Cell Biology (1 paper)PLoS neglected tropical diseases (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Bram Gerritsen
8 papers receiving 368 citations
Peers
Comparison fields: 5 of 55
- Immunology 271
- Virology 25
- Oncology 71
- Endocrinology 11
- Epidemiology 61
Countries citing papers authored by Bram Gerritsen
This map shows the geographic impact of Bram Gerritsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bram Gerritsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bram Gerritsen more than expected).
Fields of papers citing papers by Bram Gerritsen
This network shows the impact of papers produced by Bram Gerritsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bram Gerritsen. The network helps show where Bram Gerritsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bram Gerritsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 161 | |
| 2 | 2020 | 53 | |
| 3 | 2016 | 44 | |
| 4 | 2015 | 41 | |
| 5 | 2014 | 31 | |
| 6 | 2015 | 21 | |
| 7 | 2020 | 13 | |
| 8 | 2019 | 6 |
About Bram Gerritsen
Bram Gerritsen is a scholar working on Immunology, Oncology, Infectious Diseases, Molecular Biology and Virology, having authored 8 papers that have together received 370 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (2 papers), CAR-T cell therapy research (2 papers), Malaria Research and Control (1 paper), HIV Research and Treatment (1 paper), Melanoma and MAPK Pathways (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Immunology (271 citations), Virology (25 citations), Oncology (71 citations), Endocrinology (11 citations) and Epidemiology (61 citations). Bram Gerritsen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Aridaman Pandit, Rob J. de Boer, Arno C. Andeweg, David A. Price, Kristin Ladell, Can Keşmir, James E. McLaren, Gwendolyn Swarbrick, Ole Lund and Deborah A. Lewinsohn. Their work appears in journals such as eLife, The Journal of Experimental Medicine, Cell Reports, Immunology and Cell Biology and PLoS neglected tropical diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.